GlassScriptPhysician profile
Evelyne Mechas
NPI 1114667227
$6,262.11
in general payments reported to CMS, 2019-2025
16 companies · $1,731 in 2025
The $1,731 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $397 · 2023: $2,600 · 2024: $1,534 · 2025: $1,731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,954 · Travel and Lodging: $1,911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,954.25 |
| Travel and Lodging | $1,911.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $2,344.59 | 2023 | Cvi Contact Lens, Myday Contact Lens |
| Abbvie INC. | $528.14 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $485.77 | 2022-2025 | Vyzulta, Xiidra, Infuse |
| Tarsus Pharmaceuticals, INC. | $450.72 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $363.15 | 2022-2025 | Cequa |
| Johnson & Johnson Vision Care, INC. | $352.36 | 2023-2025 | Acuvue |
| Glaukos Corporation | $324.70 | 2024-2025 | Idosetr |
| Alcon Vision LLC | $322.88 | 2024-2025 | Tryptyr, Rocklatan, Simbrinza |
| Harrow Eye, LLC | $288.93 | 2024-2025 | Vevye |
| Visioneering Technologies, INC. | $266.48 | 2024 | |
| Biotissue Holdings INC. | $196.07 | 2022-2025 | |
| Astellas Pharma US INC | $125.00 | 2024 | Izervay |
| Thea Pharma INC. | $115.65 | 2024-2025 | Iyuzeh |
| Oyster Point Pharma, INC. | $52.00 | 2024-2025 | Tyrvaya, Ryzumvi |
| Mallinckrodt Hospital Products INC. | $23.75 | 2023 | Acthar |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $21.92 | 2023 | Eylea |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evelyne Mechas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.